The abstract is read at the publisher; the summary is JClub's.
Pathogenic/likely pathogenic variants in high-arrhythmogenic DCM genes (LMNA, DSP, FLNC, RBM20, PLN, SCN5A, DES, TMEM43) are linked to markedly higher major ventricular arrhythmia risk (HR 3.25) versus gene-elusive cases.
- Why it matters: DCM arrhythmia risk varies, and the magnitude of risk tied to specific arrhythmogenic genes is unclear, limiting genotype-informed sudden death prevention.
- What they did: In 2660 genotyped adults in the international SHaRe registry, researchers compared age-, sex-, and baseline LVEF-adjusted clinical outcomes across high-arrhythmogenic, low-arrhythmogenic, and gene-elusive variant groups.
- The result: High-arrhythmogenic P/LP variants increased major ventricular arrhythmia (HR 3.25), atrial fibrillation (HR 2.42), heart failure (HR 2.46), and a composite endpoint (HR 1.97), including when LVEF was ≥50%.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.